Uniderm (Clobetasol) Uses, Dosage, Side Effects and more
Uniderm (Clobetasol) is under investigation for the treatment of Scleroderma. Uniderm (Clobetasol) has been investigated for the prevention of Psoriasis and Cutaneous Atrophy Due to Corticosteroids.
| Trade Name | Uniderm (Clobetasol) |
| Availability | Prescription only |
| Generic | Clobetasol |
| Clobetasol Other Names | Clobetasol |
| Related Drugs | Humira, Cosentyx, Dupixent, prednisone, doxycycline, methotrexate, betamethasone topical, Remicade, Stelara, cyclosporine |
| Type | |
| Formula | C22H28ClFO4 |
| Weight | Average: 410.907 Monoisotopic: 410.166015296 |
| Groups | Approved, Experimental, Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | Hong Kong, Malaysia, Thailand |
| Last Updated: | January 7, 2025 at 1:49 am |
Uniderm (Clobetasol) Disease Interaction
Moderate: diabetes, diaper rash, hyperadrenocorticism, infections, ocular toxicities
